Literature DB >> 5923100

Iatrogenic asthma associated with adrenergic aerosols.

J F Keighley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5923100     DOI： 10.7326/0003-4819-65-5-985

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  20 in total

Review 1.  Lung inflammation, its significance for asthma therapy.

Authors:  J Morley; D Smith
Journal:  Agents Actions       Date:  1989-01

2.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

3.  Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Authors:  H Minatoya; B A Spilker
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

4.  Nebulizers: the patient and the prescription.

Authors:  P Barsky
Journal:  Can Med Assoc J       Date:  1973-03-17       Impact factor: 8.262

5.  Asthma deaths: a question answered.

Authors: 
Journal:  Br Med J       Date:  1972-11-25

6.  Possible adverse effects of excessive nebulized isoproterenol in status asthmaticus.

Authors:  T E Van Metre
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

7.  Laryngitis and aerosols.

Authors:  G E Stollard
Journal:  Br Med J       Date:  1970-02-28

8.  Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

Authors:  D R Taylor; M R Sears; G P Herbison; E M Flannery; C G Print; D C Lake; D M Yates; M K Lucas; Q Li
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

9.  Enhancement of airway reactivity to histamine by isoprenaline and related beta-adrenoceptor agonists in the guinea-pig.

Authors:  B C Galland; J G Blackman
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.